A detailed history of Northwest & Ethical Investments L.P. transactions in Biogen Inc. stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 2,000 shares of BIIB stock, worth $293,260. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,000 -0.0%
Holding current value
$293,260
Previous $274 Million 8.22%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$146.47 - $191.55 $795,039 - $1.04 Million
-5,428 Reduced 73.07%
2,000 $306 Million
Q3 2024

Nov 13, 2024

SELL
$189.07 - $236.8 $215,350 - $269,715
-1,139 Reduced 13.3%
7,428 $1.44 Billion
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $1.63 Million - $2.03 Million
8,567 New
8,567 $1.99 Billion
Q1 2024

Jul 09, 2025

BUY
$212.02 - $267.71 $1.39 Million - $1.76 Million
6,567 Added 328.35%
8,567 $1.85 Billion
Q3 2020

Jul 08, 2025

SELL
$264.77 - $305.71 $1.35 Million - $1.56 Million
-5,109 Closed
0 $0
Q2 2020

Jul 08, 2025

SELL
$258.66 - $342.55 $395,749 - $524,101
-1,530 Reduced 23.05%
5,109 $1.37 Billion
Q1 2020

Jul 08, 2025

SELL
$268.85 - $341.04 $26,885 - $34,104
-100 Reduced 1.48%
6,639 $2.1 Billion
Q4 2019

Jul 08, 2025

SELL
$220.06 - $304.07 $1.22 Million - $1.68 Million
-5,525 Reduced 45.05%
6,739 $2 Billion
Q3 2019

Jul 08, 2025

SELL
$217.44 - $243.88 $905,855 - $1.02 Million
-4,166 Reduced 25.36%
12,264 $2.86 Billion
Q2 2019

Jul 08, 2025

SELL
$219.29 - $241.72 $37,279 - $41,092
-170 Reduced 1.02%
16,430 $3.84 Billion
Q1 2019

Jul 08, 2025

SELL
$216.71 - $338.96 $1.68 Million - $2.63 Million
-7,764 Reduced 31.87%
16,600 $3.92 Billion
Q4 2018

Jul 08, 2025

BUY
$278.5 - $352.75 $6.23 Million - $7.89 Million
22,364 Added 1118.2%
24,364 $7.33 Billion
Q3 2018

Jul 08, 2025

BUY
$293.51 - $383.83 $4.46 Million - $5.84 Million
15,212 New
15,212 $5.37 Billion
Q2 2018

Jul 08, 2025

SELL
$257.52 - $306.91 $77,256 - $92,073
-300 Closed
0 $0
Q4 2017

Jul 08, 2025

SELL
$307.64 - $344.58 $1.08 Million - $1.21 Million
-3,500 Reduced 92.11%
300 $95.6 Million
Q3 2017

Jul 08, 2025

BUY
$281.15 - $329.69 $1 Million - $1.17 Million
3,563 Added 1503.38%
3,800 $1.19 Billion
Q1 2017

Jul 08, 2025

BUY
N/A
100 Added 72.99%
237 $64.8 Million
Q4 2016

Jul 08, 2025

SELL
N/A
-1,863 Reduced 93.15%
137 $38.9 Million
Q2 2015

Jul 08, 2025

BUY
N/A
6,500
8,500 $3.43 Billion

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Northwest & Ethical Investments L.P. Portfolio

Follow Northwest & Ethical Investments L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest & Ethical Investments L.P., based on Form 13F filings with the SEC.

News

Stay updated on Northwest & Ethical Investments L.P. with notifications on news.